The recent review spotlights the efficacy of Akkermansia muciniphila in reducing the risk and progression of metabolic syndrome and type 2 diabetes (T2D), suggesting its strong potential for use for targeted dietary interventions within probiotics.
Review hails Akkermansia as “most promising next-gen probiotic”
By 
Add A Comment